GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kingworld Medicines Group Ltd (HKSE:01110) » Definitions » YoY EPS Growth

Kingworld Medicines Group (HKSE:01110) YoY EPS Growth : 133.33% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Kingworld Medicines Group YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Kingworld Medicines Group's YoY EPS Growth for the quarter that ended in Dec. 2023 was 133.33%.

Kingworld Medicines Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was HK$0.00.


Kingworld Medicines Group YoY EPS Growth Historical Data

The historical data trend for Kingworld Medicines Group's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kingworld Medicines Group YoY EPS Growth Chart

Kingworld Medicines Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 -70.51 165.22 -31.15 66.67

Kingworld Medicines Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 450.00 20.51 -113.64 48.94 133.33

Kingworld Medicines Group YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Kingworld Medicines Group's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(0.07-0.042)/ | 0.042 |
=66.67 %

Kingworld Medicines Group's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(0.001--0.003)/ | -0.003 |
=133.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kingworld Medicines Group YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Kingworld Medicines Group's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Kingworld Medicines Group (HKSE:01110) Business Description

Traded in Other Exchanges
N/A
Address
198 Daxin Road, 8th-9th Floor, Block A, Majialong Chuangxin Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518016
Kingworld Medicines Group Ltd is engaged in Distribution sales of pharmaceutical and healthcare products such as branded imported pharmaceutical and healthcare products primarily in Hong Kong and the PRC, and Manufacturing and sales of electrotherapeutic and physiotherapeutic devices and general medical examination devices primarily carried out in the PRC. It derives the majority of its revenue from Distribution sales of pharmaceutical and healthcare products segment.

Kingworld Medicines Group (HKSE:01110) Headlines

No Headlines